JP2009167172A - 整腸及び/又は便通改善のための組成物 - Google Patents
整腸及び/又は便通改善のための組成物 Download PDFInfo
- Publication number
- JP2009167172A JP2009167172A JP2008316328A JP2008316328A JP2009167172A JP 2009167172 A JP2009167172 A JP 2009167172A JP 2008316328 A JP2008316328 A JP 2008316328A JP 2008316328 A JP2008316328 A JP 2008316328A JP 2009167172 A JP2009167172 A JP 2009167172A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- days
- dietary fiber
- water
- stool
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 230000033001 locomotion Effects 0.000 title claims abstract description 29
- 208000028774 intestinal disease Diseases 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 34
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 30
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 29
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 22
- 229920001353 Dextrin Polymers 0.000 claims abstract description 20
- 239000004375 Dextrin Substances 0.000 claims abstract description 20
- 235000019425 dextrin Nutrition 0.000 claims abstract description 20
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims abstract description 15
- 229960000511 lactulose Drugs 0.000 claims abstract description 15
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920001202 Inulin Polymers 0.000 claims abstract description 14
- 241000545263 Salacia <hydroid> Species 0.000 claims abstract description 14
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 14
- 229940029339 inulin Drugs 0.000 claims abstract description 14
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 13
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 13
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 13
- 210000000936 intestine Anatomy 0.000 claims abstract description 5
- 230000013872 defecation Effects 0.000 claims description 47
- 244000068988 Glycine max Species 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 8
- 239000005017 polysaccharide Substances 0.000 claims description 8
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 229920002907 Guar gum Polymers 0.000 claims description 6
- 239000007857 degradation product Substances 0.000 claims description 6
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 6
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 6
- 235000010417 guar gum Nutrition 0.000 claims description 6
- 239000000665 guar gum Substances 0.000 claims description 6
- 229960002154 guar gum Drugs 0.000 claims description 6
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 5
- 229920002581 Glucomannan Polymers 0.000 claims description 5
- 229920000084 Gum arabic Polymers 0.000 claims description 5
- 244000134552 Plantago ovata Species 0.000 claims description 5
- 235000003421 Plantago ovata Nutrition 0.000 claims description 5
- 229920001100 Polydextrose Polymers 0.000 claims description 5
- 239000009223 Psyllium Substances 0.000 claims description 5
- 235000010489 acacia gum Nutrition 0.000 claims description 5
- 229940046240 glucomannan Drugs 0.000 claims description 5
- 235000013856 polydextrose Nutrition 0.000 claims description 5
- 239000001259 polydextrose Substances 0.000 claims description 5
- 229940035035 polydextrose Drugs 0.000 claims description 5
- 229940070687 psyllium Drugs 0.000 claims description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 5
- 239000000661 sodium alginate Substances 0.000 claims description 5
- 229940005550 sodium alginate Drugs 0.000 claims description 5
- 235000015099 wheat brans Nutrition 0.000 claims description 5
- 239000000205 acacia gum Substances 0.000 claims description 4
- 235000013365 dairy product Nutrition 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002354 daily effect Effects 0.000 description 26
- 206010010774 Constipation Diseases 0.000 description 25
- 238000012360 testing method Methods 0.000 description 24
- 230000000968 intestinal effect Effects 0.000 description 23
- 239000000843 powder Substances 0.000 description 17
- 210000003608 fece Anatomy 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 8
- 230000033228 biological regulation Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229940068196 placebo Drugs 0.000 description 8
- 239000000902 placebo Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 150000004804 polysaccharides Chemical class 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 235000011399 aloe vera Nutrition 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000010006 flight Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- -1 Lactose oligosaccharide Chemical class 0.000 description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 4
- 240000003768 Solanum lycopersicum Species 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 102000004357 Transferases Human genes 0.000 description 4
- 108090000992 Transferases Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 235000020279 black tea Nutrition 0.000 description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000251953 Agaricus brunnescens Species 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 3
- 235000002961 Aloe barbadensis Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000004376 Sucralose Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 3
- 229940107187 fructooligosaccharide Drugs 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000008991 intestinal motility Effects 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 3
- 235000019408 sucralose Nutrition 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 2
- 240000006108 Allium ampeloprasum Species 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 241001127637 Plantago Species 0.000 description 2
- 244000294611 Punica granatum Species 0.000 description 2
- 235000014360 Punica granatum Nutrition 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 229940125722 laxative agent Drugs 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 235000015206 pear juice Nutrition 0.000 description 2
- 229940054168 pomegranate fruit extract Drugs 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 235000015193 tomato juice Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- CHUGKEQJSLOLHL-UHFFFAOYSA-N 2,2-Bis(bromomethyl)propane-1,3-diol Chemical compound OCC(CO)(CBr)CBr CHUGKEQJSLOLHL-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- FVVCFHXLWDDRHG-UHFFFAOYSA-N Nigellamose Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 FVVCFHXLWDDRHG-UHFFFAOYSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- FVVCFHXLWDDRHG-KKNDGLDKSA-N erlose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-KKNDGLDKSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011903 nutritional therapy Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000001523 saccharolytic effect Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【解決手段】 水溶性食物繊維成分として、イヌリン及び難消化性デキストリン、オリゴ糖成分として、ラクチュロース、その他の成分としてサラシアエキス及びパントテン酸を含む、整腸及び/又は便通改善のための組成物。
【選択図】 なし
Description
(1)水溶性食物繊維成分として、イヌリン及び難消化性デキストリン、オリゴ糖成分として、ラクチュロース、その他の成分としてサラシアエキス及びパントテン酸を含む、整腸及び/又は便通改善のための組成物。
(2)一日分の摂取量あたり、イヌリン2.75±0.55 g〜8.25±1.65 g、難消化性デキストリン2.75±0.55 g〜8.25±1.65 g、ラクチュロース1.0±0.2 g〜3.0±0.6 g、サラシアエキス60±12 mg〜180±36 mg、パントテン酸6.0±1.2 mg〜18.0±3.6 mgを含む(1)記載の組成物。
(3)一日分の摂取量あたり、イヌリン5.0±1.0 g、難消化性デキストリン5.0±1.0 g、ラクチュロース2.0±0.4 g、サラシアエキス180±36 mg、パントテン酸10±2 mgを含む(1)記載の組成物。
(4)さらに、水溶性食物繊維成分として、グアガム分解物、サイリウム、ポリデキストロース、水溶性大豆多糖類、低分子アルギン酸ナトリウム、グルコマンナン及びアカシアガムからなる群より選択される少なくとも1つの成分、オリゴ糖成分として、大豆オリゴ糖、フラクトオリゴ糖、乳果オリゴ糖、ガラクトオリゴ糖、キシロオリゴ糖及びイソマルトオリゴ糖からなる群より選択される少なくとも1つの成分、不溶性食物繊維成分としてセルロース及び/又は小麦ふすまを含む(1)〜(3)のいずれかに記載の組成物。
(5)一日分の摂取量あたり、水溶性食物繊維成分の総量として10.0±2.0g、オリゴ糖成分の総量として2.0±0.4g、不溶性食物繊維成分1.0〜10.0gを含む(4)記載の組成物。
(6)排便コントロール及び/又は菌交代症の予防のために用いられる(1)〜(5)のいずれかに記載の組成物。
一日摂取量18錠中、イヌリン5.0g、難消化性デキストリン5.0g、ラクチュロース2.0g、サラシアエキス180mg、パントテン酸カルシウム10mgを含む製剤(Fo-tab)を、原料の計量→造粒(粉末→顆粒)→混合→成型(打錠)→検品→包装→梱包の順で調製した。
目的:調製例1で調製した製剤のヒトにおける有効性(整腸作用・便通改善効果)を確認すること。
(1)被験者を封筒法によりランダムに割り付け、エントリーした。
(2)研究期間は30日間。服用期間は20日間。服用期間直前の10日間を観察期間とし、この期間においても評価項目の調査を行った。
(3)被験者は、18タブレット/日、継続した20日間服用した。
(4)服用方法は、食前30分を目安に、朝食前6、昼食前6、夕食前6の1日計18タブレットを服用した。
(5)食事は自由に摂取して構わないが、食物繊維の多い食事の多量摂取は避けてもらった。
(6) 被験食品(調製例1で調製した製剤)は観察期間終了後に20包(18タブレット/1包)を各被験者に配布した。
2包中、イヌリン5.5g、難消化性デキストリン5.5g、ラクチュロース(ミルクオリゴ糖)2.0g、サラシアエキス120mg、パントテン酸カルシウム12mg及び下記の各種添加剤適量を含む、3種類の飲料粉末(紅茶、フルーツトマト、ザクロ)を、原料の計量→造粒(粉末→顆粒)→混合→検品→包装→梱包の順で調製した。
・紅茶エキスパウダー(紅茶、オリゴ糖)
・環状オリゴ糖
・デキストリン
(フルーツトマト飲料粉末の添加剤)
・甘味料(アセスルファムK、ステビア)
・酸味料(クエン酸)
・トマトジュース
・香料
・トマト色素
・デキストリン
(ザクロ飲料粉末)
・ザクロ果実エキス
・香料
・ベニコウジ色素
・デキストリン
Claims (6)
- 水溶性食物繊維成分として、イヌリン及び難消化性デキストリン、オリゴ糖成分として、ラクチュロース、その他の成分としてサラシアエキス及びパントテン酸を含む、整腸及び/又は便通改善のための組成物。
- 一日分の摂取量あたり、イヌリン2.75±0.55 g〜8.25±1.65 g、難消化性デキストリン2.75±0.55 g〜8.25±1.65 g、ラクチュロース1.0±0.2 g〜3.0±0.6 g、サラシアエキス60±12 mg〜180±36 mg、パントテン酸6.0±1.2 mg〜18.0±3.6 mgを含む請求項1記載の組成物。
- 一日分の摂取量あたり、イヌリン5.0±1.0 g、難消化性デキストリン5.0±1.0 g、ラクチュロース2.0±0.4 g、サラシアエキス180±36 mg、パントテン酸10±2 mgを含む請求項1記載の組成物。
- さらに、水溶性食物繊維成分として、グアガム分解物、サイリウム、ポリデキストロース、水溶性大豆多糖類、低分子アルギン酸ナトリウム、グルコマンナン及びアカシアガムからなる群より選択される少なくとも1つの成分、オリゴ糖成分として、大豆オリゴ糖、フラクトオリゴ糖、乳果オリゴ糖、ガラクトオリゴ糖、キシロオリゴ糖及びイソマルトオリゴ糖からなる群より選択される少なくとも1つの成分、不溶性食物繊維成分としてセルロース及び/又は小麦ふすまを含む請求項1〜3のいずれかに記載の組成物。
- 一日分の摂取量あたり、水溶性食物繊維成分の総量として10.0±2.0g、オリゴ糖成分の総量として2.0±0.4g、不溶性食物繊維成分1.0〜10.0gを含む請求項4記載の組成物。
- 排便コントロール及び/又は菌交代症の予防のために用いられる請求項1〜5のいずれかに記載の組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008316328A JP5992654B2 (ja) | 2007-12-21 | 2008-12-12 | 整腸及び/又は便通改善のための組成物 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007330428 | 2007-12-21 | ||
JP2007330428 | 2007-12-21 | ||
JP2008316328A JP5992654B2 (ja) | 2007-12-21 | 2008-12-12 | 整腸及び/又は便通改善のための組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016102998A Division JP2016172761A (ja) | 2007-12-21 | 2016-05-24 | 整腸及び/又は便通改善のための組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009167172A true JP2009167172A (ja) | 2009-07-30 |
JP5992654B2 JP5992654B2 (ja) | 2016-09-14 |
Family
ID=40968788
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008316328A Active JP5992654B2 (ja) | 2007-12-21 | 2008-12-12 | 整腸及び/又は便通改善のための組成物 |
JP2016102998A Pending JP2016172761A (ja) | 2007-12-21 | 2016-05-24 | 整腸及び/又は便通改善のための組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016102998A Pending JP2016172761A (ja) | 2007-12-21 | 2016-05-24 | 整腸及び/又は便通改善のための組成物 |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP5992654B2 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012102036A (ja) * | 2010-11-09 | 2012-05-31 | Hymo Corp | 便通改善用組成物及びそれを含有する飲食品およびその使用方法 |
JP2014070023A (ja) * | 2012-09-27 | 2014-04-21 | Kobayashi Pharmaceutical Co Ltd | 便通改善用経口組成物 |
EP2498626B1 (en) | 2009-11-12 | 2015-06-17 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
CN105087638A (zh) * | 2010-04-08 | 2015-11-25 | 佛罗里达大学研究基金会有限公司 | 具有多功能的瞬时表达病毒载体体系 |
JP2016098184A (ja) * | 2014-11-19 | 2016-05-30 | 富士フイルム株式会社 | サラシア属植物の抽出物を含む錠剤及びその製造方法 |
WO2019160024A1 (ja) * | 2018-02-16 | 2019-08-22 | 森永乳業株式会社 | 血圧降下用及び/又は中性脂肪低減用の組成物 |
JP2020127392A (ja) * | 2019-02-12 | 2020-08-27 | フジ日本精糖株式会社 | イヌリンを含む整腸剤 |
WO2024143197A1 (ja) * | 2022-12-26 | 2024-07-04 | セトラスホールディングス株式会社 | 配合剤及びそれを用いた処置方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108686098A (zh) * | 2018-08-16 | 2018-10-23 | 甘肃百草堂医药科技有限公司 | 一种用于清肠通便的中药组合物 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000191524A (ja) * | 1998-12-25 | 2000-07-11 | Pasuteru:Kk | 便秘改善組成物 |
JP2002104980A (ja) * | 2000-09-25 | 2002-04-10 | Takama:Kk | 消化器系運動亢進剤 |
JP2006025660A (ja) * | 2004-07-14 | 2006-02-02 | Sangi Co Ltd | おから茶飲料 |
WO2006054710A1 (ja) * | 2004-11-22 | 2006-05-26 | Sunstar Inc. | 最大消化管通過時間改善剤、消化管通過時間改善剤及び大腸癌予防剤 |
JP2006522766A (ja) * | 2003-04-08 | 2006-10-05 | ノバルティス アクチエンゲゼルシャフト | シンビオティックな組み合わせ |
JP2007031345A (ja) * | 2005-07-27 | 2007-02-08 | Seiko:Kk | 腸内環境改善作用を有する食品組成物 |
-
2008
- 2008-12-12 JP JP2008316328A patent/JP5992654B2/ja active Active
-
2016
- 2016-05-24 JP JP2016102998A patent/JP2016172761A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000191524A (ja) * | 1998-12-25 | 2000-07-11 | Pasuteru:Kk | 便秘改善組成物 |
JP2002104980A (ja) * | 2000-09-25 | 2002-04-10 | Takama:Kk | 消化器系運動亢進剤 |
JP2006522766A (ja) * | 2003-04-08 | 2006-10-05 | ノバルティス アクチエンゲゼルシャフト | シンビオティックな組み合わせ |
JP2006025660A (ja) * | 2004-07-14 | 2006-02-02 | Sangi Co Ltd | おから茶飲料 |
WO2006054710A1 (ja) * | 2004-11-22 | 2006-05-26 | Sunstar Inc. | 最大消化管通過時間改善剤、消化管通過時間改善剤及び大腸癌予防剤 |
JP2007031345A (ja) * | 2005-07-27 | 2007-02-08 | Seiko:Kk | 腸内環境改善作用を有する食品組成物 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2498626B1 (en) | 2009-11-12 | 2015-06-17 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
US10015978B2 (en) | 2009-11-12 | 2018-07-10 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
CN105087638A (zh) * | 2010-04-08 | 2015-11-25 | 佛罗里达大学研究基金会有限公司 | 具有多功能的瞬时表达病毒载体体系 |
JP2012102036A (ja) * | 2010-11-09 | 2012-05-31 | Hymo Corp | 便通改善用組成物及びそれを含有する飲食品およびその使用方法 |
JP2014070023A (ja) * | 2012-09-27 | 2014-04-21 | Kobayashi Pharmaceutical Co Ltd | 便通改善用経口組成物 |
JP2016098184A (ja) * | 2014-11-19 | 2016-05-30 | 富士フイルム株式会社 | サラシア属植物の抽出物を含む錠剤及びその製造方法 |
WO2019160024A1 (ja) * | 2018-02-16 | 2019-08-22 | 森永乳業株式会社 | 血圧降下用及び/又は中性脂肪低減用の組成物 |
JP2020127392A (ja) * | 2019-02-12 | 2020-08-27 | フジ日本精糖株式会社 | イヌリンを含む整腸剤 |
WO2024143197A1 (ja) * | 2022-12-26 | 2024-07-04 | セトラスホールディングス株式会社 | 配合剤及びそれを用いた処置方法 |
Also Published As
Publication number | Publication date |
---|---|
JP2016172761A (ja) | 2016-09-29 |
JP5992654B2 (ja) | 2016-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5992654B2 (ja) | 整腸及び/又は便通改善のための組成物 | |
Ahmed et al. | Functional and therapeutic potential of inulin: A comprehensive review | |
ES2258076T3 (es) | Productos de inulina con propiedades nutricionales mejoradas. | |
de Sousa et al. | The importance of prebiotics in functional foods and clinical practice | |
Di Bartolomeo et al. | Prebiotics to fight diseases: reality or fiction? | |
US10440982B2 (en) | Cereal-based infant nutrition with fibre | |
Singh et al. | Prebiotic potential of oligosaccharides: A focus on xylan derived oligosaccharides | |
ES2383314T3 (es) | Mezcla de fibras pediátrica | |
RU2358474C2 (ru) | Пребиотические композиции | |
Boeckner et al. | Inulin: a review of nutritional and health implications | |
JP4504683B2 (ja) | ソフトドリンク代替品 | |
Geyer et al. | Effect of yacon (Smallanthus sonchifolius) on colonic transit time in healthy volunteers | |
JP2014532725A (ja) | 下剤および食品サプリメントとしての濃縮プルーンおよびプレバイオティクスの製剤 | |
JP2014513965A (ja) | 食物繊維の混合物を含む組成物 | |
Sebastián et al. | Prebiotics in beverages: from health impact to preservation | |
Ferreira et al. | An overview of prebiotics and their applications in the food industry | |
JP2015202057A (ja) | 食物繊維入りヨーグルトの製造方法 | |
Sharma et al. | Prebiotics: A review of therapeutic potential | |
Donadio et al. | Comparative analysis of pectin and prebiotics on human microbiota modulation in early life stages and adults | |
Kuthiala et al. | Benefits of functional oligosaccharides (FOS) in treating functional bowel disorders (FBD) and low caloric substitutes for diabetics | |
JP4894044B2 (ja) | 腸内環境改善組成物、甘味組成物および機能性食品 | |
CN112641098A (zh) | 一种具有调理肠胃腹泻功能的阿拉伯胶组合物 | |
WO2005072750A1 (ja) | 食事性脂質吸収阻害用組成物 | |
Meunier et al. | Locust bean gum safety in neonates and young infants: An integrated | |
Akdevelioğlu | Prebiyotikler Nedir, Ne Değildir. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111107 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130528 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130712 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140210 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140527 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160524 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160818 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5992654 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |